TNF and combined immunodeficiency: To answer this question, we analyzed IgG Fc N-glycan profiles in CID patients on azathioprine and biological therapies: anti-TNF and anti-α4β7 integrin monoclonal antibodies—infliximab and vedolizumab, respectively.